you can see clearly now
MacuCLEAR, Inc. is focused on the design and development of small molecule products for ophthalmic and other indications. We are developing innovative eye drops to treat age-related diseases, including the leading causes of blindness and vision impairment. MacuCLEAR is driving innovation with the development of an eye drop treatment for the dry form of AMD, which affects around 13 million Americans and 27 million people globally. Learn More